v.231201
Showing details for project SYSMHC00075
SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
SYSMHC00075_LA3ST_Orbitrap |
4 |
Human |
|
|
DRB1_0301,DRB1_1501 |
SYSMHC00075_LA4ST_Orbitrap |
4 |
Human |
|
|
DRB1_1101,DRB1_1302 |
SYSMHC00075_LA5PB_Orbitrap |
5 |
Human |
|
|
DRB1_0301,DRB1_0305 |
SYSMHC00075_LA5SF_Orbitrap |
5 |
Human |
|
|
DRB1_0301,DRB1_0305 |
SYSMHC00075_LA5ST_Orbitrap |
4 |
Human |
|
|
DRB1_0301,DRB1_0305 |
SYSMHC00075_LA6PB_QEp |
1 |
Human |
|
|
DRB1_0103,DRB1_0301 |
SYSMHC00075_LA6ST_Orbitrap |
2 |
Human |
|
|
DRB1_0103,DRB1_0301 |
SYSMHC00075_LA7SF_QEp |
1 |
Human |
|
|
DRB1_0403,DRB1_1501 |
SYSMHC00075_LA7ST_Orbitrap |
2 |
Human |
|
|
DRB1_0403,DRB1_1501 |
SYSMHC00075_LA8SF_QEp |
2 |
Human |
|
|
DRB1_0401,DRB1_1001 |
SYSMHC00075_LA8ST_QEp |
1 |
Human |
|
|
DRB1_0401,DRB1_1001 |
SYSMHC00075_RA2PB_Orbitrap |
4 |
Human |
|
|
DRB1_0401,DRB1_0101 |
SYSMHC00075_RA2PB_QEp |
1 |
Human |
|
|
DRB1_0401,DRB1_0101 |
SYSMHC00075_RA2SF_Orbitrap |
5 |
Human |
|
|
DRB1_0401,DRB1_0101 |
SYSMHC00075_RA2SF_QEp |
1 |
Human |
|
|
DRB1_0401,DRB1_0101 |
SYSMHC00075_RA2ST_QEp |
1 |
Human |
|
|
DRB1_0401,DRB1_0101 |
SYSMHC00075_RA3ST_Orbitrap |
4 |
Human |
|
|
DRB1_0401,DRB1_0101 |
SYSMHC00075_RA4PB_Orbitrap |
3 |
Human |
|
|
DRB1_0401,DRB1_1501 |
SYSMHC00075_RA4SF_Orbitrap |
3 |
Human |
|
|
DRB1_0401,DRB1_1501 |
SYSMHC00075_RA5ST_Orbitrap |
4 |
Human |
|
|
DRB1_0801,DRB1_1501 |
Detailed view of sample SYSMHC00075_RA3ST_Orbitrap
ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue Type |
Cell Type |
Culture Conditions |
Disease State |
Comments |
MHCClass |
MHCAllele |
PubMed ID |
Peptide |
Isolation Method |
Antibody |
Mass Spectrometer |
LC System |
iRT Peptides |
Acquisition Mode |
Fragmentation Method |
Gradient |
Gradient Length |
Flow Rate |
Replicate Number |
ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue_Type |
Cell_Type |
Culture_Conditions |
Disease_State |
Comments |
MHCClass |
MHCAllele |
PubMed_ID |
Peptide |
Isolation_Method |
Antibody |
Mass_Spectrometer |
LC_System |
iRT_Peptides |
Acquisition_Mode |
Fragmentation_Method |
Gradient |
Gradient_Length |
Flow_Rate |
Replicate_Number |
SYSMHC00075 |
SYSMHC00075_RA3ST_Orbitrap |
RA3ST_1_Orbitrap.RAW |
Human |
In vitro |
Synovium |
PBMC |
suspension |
Rheumatoid arthritis |
|
class II |
DRB1_0401,DRB1_0101 |
PXD003051 |
native |
Immunoaffinity |
L243 |
LTQ Orbitrap |
|
no |
DDA |
CID |
2-40%(0.1% FA and 1% H2O) |
52 |
|
1 |
SYSMHC00075 |
SYSMHC00075_RA3ST_Orbitrap |
RA3ST_2_Orbitrap.RAW |
Human |
In vitro |
Synovium |
PBMC |
suspension |
Rheumatoid arthritis |
|
class II |
DRB1_0401,DRB1_0101 |
PXD003051 |
native |
Immunoaffinity |
L243 |
LTQ Orbitrap |
|
no |
DDA |
CID |
2-40%(0.1% FA and 1% H2O) |
52 |
|
2 |
SYSMHC00075 |
SYSMHC00075_RA3ST_Orbitrap |
RA3ST_3_Orbitrap.RAW |
Human |
In vitro |
Synovium |
PBMC |
suspension |
Rheumatoid arthritis |
|
class II |
DRB1_0401,DRB1_0101 |
PXD003051 |
native |
Immunoaffinity |
L243 |
LTQ Orbitrap |
|
no |
DDA |
CID |
2-40%(0.1% FA and 1% H2O) |
52 |
|
3 |
SYSMHC00075 |
SYSMHC00075_RA3ST_Orbitrap |
RA3ST_4_Orbitrap.RAW |
Human |
In vitro |
Synovium |
PBMC |
suspension |
Rheumatoid arthritis |
|
class II |
DRB1_0401,DRB1_0101 |
PXD003051 |
native |
Immunoaffinity |
L243 |
LTQ Orbitrap |
|
no |
DDA |
CID |
2-40%(0.1% FA and 1% H2O) |
52 |
|
4 |